Post-treatment support program to help Black women breast cancer survivors in Western New York transition into survivorship

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The program delivers no-cost, culturally tailored survivorship support to up to 100 breast cancer survivors in Western New York, prioritizing those who are African American and those within one year of completing primary treatment. Participants join two-hour group sessions on the 1st and 3rd Thursdays of each month and meet with a long-term survivor mentor for one-on-one sessions on the 2nd and 4th Thursdays for up to 12 months. Mentors support monthly self-assessments, help identify and address modifiable risk factors, and connect mentees to local resources and providers as needed. The project will measure feasibility, acceptability, participant quality of life, and factors affecting sustainability and potential spread to other National Witness Project® sites.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Ability to speak and read English
* At least 18 years of age or older
* Live in the Western New York area
* Has been diagnosed with breast cancer (any stage)
* Has completed primary breast cancer treatments (i.e., systemic, radiation, and/or surgical interventions other than breast reconstruction surgeries)

  * Mentors are at least one-year post-treatment completion
  * Mentees are less than one-year post-treatment completion
  * Note: Individuals who have completed primary breast cancer treatments who are being managed with ongoing hormonal therapies and/or are awaiting breast reconstruction surgery may participate in this study (i.e., these therapies do not meet exclusion criteria)

    * Note: Although any breast cancer survivor may participate, priority will be given to those who have most recently transitioned into their post-treatment life (or those who report that support was either not offered or was unavailable to them during their less recent transition into post-treatment life) and /or self-identify as African American

Exclusion Criteria:

* Currently receiving neoadjuvant and/or adjuvant systemic and/or radiations therapies
* Unwilling or unable to complete the assessment in English
* Are pregnant or nursing
* Are unwilling or unable to follow protocol requirements

  * Note: Individuals who have completed primary breast cancer treatments who are being managed with ongoing hormonal therapies and/or are awaiting breast reconstruction surgery may participate in this study (i.e., these therapies do not meet exclusion criteria)

Where it's running

• Roswell Park Cancer Institute
  Buffalo, New York, United States Recruiting

Study contacts

• Principal investigator: Julia Devonish — Roswell Park Cancer Institute

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Mobile health navigation to improve breast cancer screening in Kenyan women

  This study tests m-Health patient navigation tools to help women in Kenya access breast cancer screening and early detection services.

  Recruiting Emory University · Atlanta, Georgia · NCT07764796

• Blended e-Health Program to Help Women with Breast or Gynecologic Cancer Manage Fear of Cancer Progression

  This trial tests a blended online and group program to see if it helps women with breast or gynecologic cancer feel less fear that their cancer could grow or spread.

  Recruiting at 11 sites City of Hope Medical Center · Arcadia, California and 10 other locations · NCT07741968

• Environmental exposure checks in high-risk and early-onset breast cancer care

  This study tests how patients and providers feel about using environmental exposure risk data in breast cancer care for women at average/high risk or with early-onset breast cancer.

  Recruiting City of Hope Medical Center · Duarte, California · NCT07690852

• CSF sample collection from people with metastatic breast cancer to see brain metastasis risk

  This study tests whether spinal fluid and other samples can help predict brain metastases in adults with metastatic HER2-positive or triple-negative breast cancer who have not yet shown brain involvement.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07619534

• Body composition and outcomes after breast reconstruction

  This study will see if detailed body composition measurements can help predict complications after mastectomy with immediate breast reconstruction in adult women.

  Recruiting University of California, San Francisco · San Francisco, California · NCT07546331

• Support tool for women with HR+ breast cancer on long-term endocrine therapy

  This study tests a SHIELD web- and app-based portal to help women with hormone receptor–positive breast cancer manage symptoms while on long-term endocrine treatment.

  Recruiting Dana-Farber Cancer Institute · Boston, Massachusetts · NCT07482384

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.